Purpose of review In both Crohn's disease and ulcerative I colitis, the tissue damage results from an inappropriate or exaggerated immune response to antigens of the gut microflora. This review summarizes current knowledge regarding the role of immune-inflammatory mediators in the pathogenesis of inflammatory bowel disease. Recent findings Despite having a common basis in overresponsiveness to luminal antigens, Crohn's disease and ulcerative colitis are immunologically distinct entities. Crohn's disease is associated with a Th1 T cell-mediated response, characterized by enhanced production of interferon-gamma and tumor necrosis factor-alpha. Interleukin (IL)-12 and, possibly, IL-23 govern the, Th1 cell differentiation, but optimal induction and stabilization of polarized Thl cells would require additional cytokines, such as IL-15, IL-18 and IL-21. In ulcerative colitis, the local immune response is less polarized, but it is characterized by CD1-reactive natural killer T cell production of IL-13. Beyond these differences, Crohn's disease and ulcerative colitis share important end-stage effector pathways of intestinal injury, which are mediated by an active cross-talk between immune and non-immune mucosal cells. Summary The clarification of the complex network of immune-inflammatory mediators operating in the gut of patients with inflammatory bowel disease has led to the identification of new targets that could, in turn, drive the development of effective biological therapies.

Monteleone G., F.D. (2006). New mediators of immunity and inflammation in inflammatory bowel disease. CURRENT OPINION IN GASTROENTEROLOGY, 22(4), 361-364 [10.1097/01.mog.0000231808.10773.8e].

New mediators of immunity and inflammation in inflammatory bowel disease

MONTELEONE, GIOVANNI;PALLONE, FRANCESCO
2006

Abstract

Purpose of review In both Crohn's disease and ulcerative I colitis, the tissue damage results from an inappropriate or exaggerated immune response to antigens of the gut microflora. This review summarizes current knowledge regarding the role of immune-inflammatory mediators in the pathogenesis of inflammatory bowel disease. Recent findings Despite having a common basis in overresponsiveness to luminal antigens, Crohn's disease and ulcerative colitis are immunologically distinct entities. Crohn's disease is associated with a Th1 T cell-mediated response, characterized by enhanced production of interferon-gamma and tumor necrosis factor-alpha. Interleukin (IL)-12 and, possibly, IL-23 govern the, Th1 cell differentiation, but optimal induction and stabilization of polarized Thl cells would require additional cytokines, such as IL-15, IL-18 and IL-21. In ulcerative colitis, the local immune response is less polarized, but it is characterized by CD1-reactive natural killer T cell production of IL-13. Beyond these differences, Crohn's disease and ulcerative colitis share important end-stage effector pathways of intestinal injury, which are mediated by an active cross-talk between immune and non-immune mucosal cells. Summary The clarification of the complex network of immune-inflammatory mediators operating in the gut of patients with inflammatory bowel disease has led to the identification of new targets that could, in turn, drive the development of effective biological therapies.
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/12 - Gastroenterologia
English
Crohn's disease; interleukin-12; interieukin-13; interieukin-21; interleukin-22; NKT cells; T cells; ulcerative colitis
Monteleone G., F.D. (2006). New mediators of immunity and inflammation in inflammatory bowel disease. CURRENT OPINION IN GASTROENTEROLOGY, 22(4), 361-364 [10.1097/01.mog.0000231808.10773.8e].
Monteleone, G; Fina, D; Caruso, R; Pallone, F
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/28813
Citazioni
  • ???jsp.display-item.citation.pmc??? 28
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 71
social impact